Review: taking Amitiza and Miralax together


Summary

Drug interactions are reported among people who take Amitiza and Miralax together. This review analyzes the effectiveness and drug interactions between Amitiza and Miralax. It is created by eHealthMe based on reports of 312 people who take the same drugs from FDA and social media, and is updated regularly.

You are not alone

Join a support group for people who take Amitiza and Miralax >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Amitiza

Amitiza has active ingredients of lubiprostone. It is often used in constipation. (latest outcomes from Amitiza 2,379 users)

Miralax

Miralax has active ingredients of polyethylene glycol 3350. It is often used in constipation. (latest outcomes from Miralax 15,544 users)

On Aug, 27, 2016

312 people who take Amitiza, Miralax are studied.


Number of reports submitted per year:

Amitiza and Miralax drug interactions.

Drug effectiveness over time:

Amitiza:
  • < 1 month: 0.0% - (0 of 1 people)
  • 1 - 6 months: 0.0% - (0 of 1 people)
  • 6 - 12 months: 0.0% - (0 of 1 people)
  • 1 - 2 years: 0.0% - (0 of 1 people)
  • 2 - 5 years: 0.0% - (0 of 3 people)
  • 5 - 10 years: 100.0% - (1 of 1 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)
Miralax:
  • < 1 month: 0.0% - (0 of 0 people)
  • 1 - 6 months: 0.0% - (0 of 1 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 100.0% - (1 of 1 people)
  • 2 - 5 years: 100.0% - (1 of 1 people)
  • 5 - 10 years: 25.0% - (1 of 4 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Amitiza:
  • female: 0.0% - (0 of 4 people)
  • male: 25.0% - (1 of 4 people)
Miralax:
  • female: 66.0% - (2 of 3 people)
  • male: 25.0% - (1 of 4 people)

Drug effectiveness by age:

Amitiza:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 2 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 0.0% - (0 of 0 people)
  • 40-49: 0.0% - (0 of 2 people)
  • 50-59: 0.0% - (0 of 1 people)
  • 60+: 33.0% - (1 of 3 people)
Miralax:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 2 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 0.0% - (0 of 0 people)
  • 40-49: 100.0% - (1 of 1 people)
  • 50-59: 0.0% - (0 of 1 people)
  • 60+: 66.0% - (2 of 3 people)

Most common drug interactions over time *:

< 1 month:
  • dyspnoea
  • diarrhoea
  • abdominal pain
  • drug ineffective
  • muscle spasms
  • vomiting
  • chest discomfort
  • abdominal distension
  • abdominal tenderness
  • chest pain
1 - 6 months:
  • fall
  • anxiety
  • back injury
  • depression
  • face injury
  • mouth injury
  • osteomyelitis
  • osteonecrosis
  • road traffic accident
  • spinal cord disorder
6 - 12 months:
  • abdominal distension
  • drug ineffective
  • haemorrhoids
  • hypoaesthesia
  • muscle spasms
  • nausea
  • oedema peripheral
  • pyrexia
  • anorectal infection
  • anorexia
1 - 2 years:
  • tardive dyskinesia
2 - 5 years:
  • gastroparesis
  • high blood pressure
  • colonic polyp
  • drug ineffective
  • nausea
  • asthma
  • constipation
  • drug effect decreased
  • ehlers-danlos syndrome
  • epilepsy
5 - 10 years:
  • stomach pain
  • drug effect decreased
not specified:
  • pain
  • constipation
  • anxiety
  • nausea
  • dyspnoea
  • diarrhoea
  • abdominal pain
  • gastrooesophageal reflux disease
  • pyrexia
  • vomiting

Most common drug interactions by gender *:

female:
  • pain
  • constipation
  • anxiety
  • nausea
  • dyspnoea
  • diarrhoea
  • abdominal pain upper
  • vomiting
  • abdominal pain
  • oedema peripheral
male:
  • constipation
  • dyspnoea
  • diarrhoea
  • abdominal pain
  • asthenia
  • pain
  • dizziness
  • anxiety
  • back pain
  • blood glucose increased

Most common drug interactions by age *:

2-9:
  • chest discomfort
  • chest pain
  • drug ineffective
  • lactose intolerance
  • muscle spasms
  • terminal insomnia
  • abdominal pain
  • abdominal pain lower
  • abnormal behaviour
  • aggression
10-19:
  • cholecystitis
  • vomiting
  • abdominal pain upper
  • back pain
  • cholecystitis chronic
  • diarrhoea
  • gastrointestinal disorder
  • nausea
  • pain
  • chest discomfort
20-29:
  • pain
  • abdominal pain upper
  • cholecystitis chronic
  • cholelithiasis
  • gallbladder disorder
  • chest pain
  • dyspnoea
  • injection site pain
  • injury
  • nausea
30-39:
  • carcinoid tumour of the appendix
  • renal cancer
  • gastric cancer
  • convulsion
  • confusional state
  • drug exposure during pregnancy
  • dyspnoea
  • hallucination
  • pregnancy
  • abdominal pain
40-49:
  • pain
  • anxiety
  • dyspnoea
  • constipation
  • bone disorder
  • pyrexia
  • swelling
  • osteomyelitis
  • osteonecrosis of jaw
  • sinusitis
50-59:
  • pain
  • abdominal pain
  • fall
  • diarrhoea
  • constipation
  • gastrooesophageal reflux disease
  • nausea
  • dyspnoea
  • anxiety
  • oedema peripheral
60+:
  • constipation
  • pain
  • drug ineffective
  • back pain
  • dizziness
  • asthenia
  • diarrhoea
  • vomiting
  • chest pain
  • nausea

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Amitiza and Miralax?

Can you answer these questions?

More questions for: Amitiza, Miralax

You may be interested in these reviews

More reviews for: Amitiza, Miralax

On eHealthMe, Amitiza (lubiprostone) is often used to treat constipation. Miralax (polyethylene glycol 3350) is often used to treat constipation. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.